Simulations Plus Current Ratio 2010-2024 | SLP
Simulations Plus current ratio from 2010 to 2024. Current ratio can be defined as a liquidity ratio that measures a company's ability to pay short-term obligations.
| Simulations Plus Current Ratio Historical Data |
| Date |
Current Assets |
Current Liabilities |
Current Ratio |
| 2024-02-29 |
$0.13B |
$0.02B |
8.81 |
| 2023-11-30 |
$0.13B |
$0.01B |
15.10 |
| 2023-08-31 |
$0.13B |
$0.01B |
10.88 |
| 2023-05-31 |
$0.14B |
$0.01B |
15.22 |
| 2023-02-28 |
$0.13B |
$0.01B |
21.91 |
| 2022-11-30 |
$0.15B |
$0.01B |
18.50 |
| 2022-08-31 |
$0.15B |
$0.01B |
18.98 |
| 2022-05-31 |
$0.15B |
$0.01B |
24.49 |
| 2022-02-28 |
$0.14B |
$0.01B |
15.95 |
| 2021-11-30 |
$0.14B |
$0.01B |
14.55 |
| 2021-08-31 |
$0.14B |
$0.01B |
12.04 |
| 2021-05-31 |
$0.14B |
$0.01B |
18.90 |
| 2021-02-28 |
$0.14B |
$0.01B |
20.72 |
| 2020-11-30 |
$0.13B |
$0.01B |
23.96 |
| 2020-08-31 |
$0.13B |
$0.01B |
23.45 |
| 2020-05-31 |
$0.02B |
$0.01B |
2.85 |
| 2020-02-29 |
$0.03B |
$0.01B |
4.50 |
| 2019-11-30 |
$0.02B |
$0.01B |
4.10 |
| 2019-08-31 |
$0.02B |
$0.01B |
4.43 |
| 2019-05-31 |
$0.02B |
$0.01B |
4.19 |
| 2019-02-28 |
$0.02B |
$0.01B |
3.68 |
| 2018-11-30 |
$0.02B |
$0.01B |
3.43 |
| 2018-08-31 |
$0.02B |
$0.01B |
3.69 |
| 2018-05-31 |
$0.02B |
$0.01B |
3.33 |
| 2018-02-28 |
$0.02B |
$0.01B |
2.78 |
| 2017-11-30 |
$0.01B |
$0.01B |
2.47 |
| 2017-08-31 |
$0.01B |
$0.00B |
6.20 |
| 2017-05-31 |
$0.02B |
$0.00B |
11.79 |
| 2017-02-28 |
$0.01B |
$0.00B |
6.54 |
| 2016-11-30 |
$0.01B |
$0.00B |
6.07 |
| 2016-08-31 |
$0.01B |
$0.00B |
5.98 |
| 2016-05-31 |
$0.01B |
$0.00B |
3.37 |
| 2016-02-29 |
$0.01B |
$0.00B |
3.54 |
| 2015-11-30 |
$0.01B |
$0.00B |
3.17 |
| 2015-08-31 |
$0.01B |
$0.00B |
3.19 |
| 2015-05-31 |
$0.01B |
$0.00B |
6.89 |
| 2015-02-28 |
$0.01B |
$0.00B |
7.31 |
| 2014-11-30 |
$0.01B |
$0.00B |
5.99 |
| 2014-08-31 |
$0.01B |
$0.00B |
8.29 |
| 2014-05-31 |
$0.01B |
$0.00B |
7.64 |
| 2014-02-28 |
$0.01B |
$0.00B |
14.08 |
| 2013-11-30 |
$0.01B |
$0.00B |
16.61 |
| 2013-08-31 |
$0.01B |
$0.00B |
20.71 |
| 2013-05-31 |
$0.01B |
$0.00B |
13.05 |
| 2013-02-28 |
$0.01B |
$0.00B |
15.12 |
| 2012-11-30 |
$0.01B |
$0.00B |
18.65 |
| 2012-08-31 |
$0.02B |
$0.00B |
10.37 |
| 2012-05-31 |
$0.02B |
$0.00B |
8.15 |
| 2012-02-29 |
$0.02B |
$0.00B |
6.28 |
| 2011-11-30 |
$0.02B |
$0.00B |
13.26 |
| 2011-08-31 |
$0.01B |
$0.00B |
11.63 |
| 2011-05-31 |
$0.01B |
$0.00B |
7.91 |
| 2011-02-28 |
$0.01B |
$0.00B |
8.49 |
| 2010-11-30 |
$0.01B |
$0.00B |
10.80 |
| 2010-08-31 |
$0.01B |
$0.00B |
10.33 |
| 2010-05-31 |
$0.01B |
$0.00B |
9.20 |
| 2010-02-28 |
$0.01B |
$0.00B |
8.87 |
| 2009-11-30 |
$0.01B |
$0.00B |
8.81 |
| 2009-08-31 |
$0.01B |
$0.00B |
11.03 |
| 2009-05-31 |
$0.01B |
$0.00B |
10.27 |
| 2009-02-28 |
$0.01B |
$0.00B |
7.70 |
| Sector |
Industry |
Market Cap |
Revenue |
| Computer and Technology |
Computer Software |
$0.919B |
$0.060B |
|
Simulations Plus, Inc., is a premier developer of groundbreaking drug discovery and development simulation software, which is licensed to and used in the conduct of drug research by major pharmaceutical and biotechnology companies worldwide. They have two other businesses, Words+, Inc. and FutureLab, which are based on its proprietary software technologies.
|
